GlassScriptPhysician profile
Yonatan Hirsch
NPI 1699424846
$3,434.93
in general payments reported to CMS, 2019-2025
13 companies · $1,894 in 2025
The $1,894 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $539 · 2024: $1,002 · 2025: $1,894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,172 · Education: $242 · Travel and Lodging: $20.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,172.14 |
| Education | $241.99 |
| Travel and Lodging | $20.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $884.92 | 2023-2025 | |
| Genzyme Corporation | $836.85 | 2023-2025 | |
| Janssen Biotech, INC. | $609.61 | 2023-2025 | Tremfya |
| Lilly USA, LLC | $479.25 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $178.32 | 2024-2025 | Libtayo |
| Sanofi-Aventis U.S. LLC | $85.00 | 2025 | |
| Sun Pharmaceutical Industries INC. | $84.99 | 2025 | |
| Novartis Pharmaceuticals Corporation | $64.47 | 2025 | |
| Tactile Systems Technology INC | $63.62 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Takeda Pharmaceuticals U.S.A., INC. | $49.38 | 2025 | |
| Merz North America, INC. | $38.67 | 2025 | |
| Ucb, INC. | $34.14 | 2025 | Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.71 | 2023 | Spevigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yonatan Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.